BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36980984)

  • 1. Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis.
    Barnaś E; Skręt-Magierło JE; Paszek S; Kaznowska E; Potocka N; Skręt A; Sakowicz A; Zawlik I
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
    Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J
    Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From 2646 to 15: differentially regulated microRNAs between progenitors from normal myometrium and leiomyoma.
    Lazzarini R; Caffarini M; Delli Carpini G; Ciavattini A; Di Primio R; Orciani M
    Am J Obstet Gynecol; 2020 Jun; 222(6):596.e1-596.e9. PubMed ID: 31874141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous leiomyomatosis of the uterus: A clinicopathologic analysis of 13 cases with an emphasis on histogenesis.
    Tang L; Lu B
    Pathol Res Pract; 2018 Jun; 214(6):871-875. PubMed ID: 29699902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rare tumours of myometrium--intravenous leiomyomatosis and benign metastatic leiomyoma].
    Tomsová M; Pohnĕtalová D; Spacek J
    Ceska Gynekol; 2007 Apr; 72(2):136-9. PubMed ID: 17639737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and clinicopathologic characterization of intravenous leiomyomatosis.
    Ordulu Z; Chai H; Peng G; McDonald AG; De Nictolis M; Garcia-Fernandez E; Hardisson D; Prat J; Li P; Hui P; Oliva E; Buza N
    Mod Pathol; 2020 Sep; 33(9):1844-1860. PubMed ID: 32341498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.
    de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory.
    Lee HJ; Choi J; Kim KR
    Int J Gynecol Pathol; 2008 Jul; 27(3):340-5. PubMed ID: 18580311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous leiomyomatosis of the uterus.
    Arora R; Abou-Bakr AA; Ahmad MS
    Gulf J Oncolog; 2010 Jan; (7):57-9. PubMed ID: 20164011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case.
    Quade BJ; Dal Cin P; Neskey DM; Weremowicz S; Morton CC
    Mod Pathol; 2002 Mar; 15(3):351-6. PubMed ID: 11904348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.
    Wang W; Wang Y; Chen F; Zhang M; Jia R; Liu X; Zhang C; Shao J; Cheng N; Ma G; Zhu Z; Miao Q; Liang Z
    Cancer Med; 2020 Jul; 9(13):4581-4592. PubMed ID: 32372565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
    Bodner-Adler B; Bartl M; Wagner G
    Anticancer Res; 2009 Feb; 29(2):495-6. PubMed ID: 19331193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous leiomyomatosis of the uterus.
    Lösch A; Kainz C; Gitsch G; Breitenecker G
    Gen Diagn Pathol; 1995 May; 141(1):75-9. PubMed ID: 8542511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.
    Ordulu Z; Nucci MR; Dal Cin P; Hollowell ML; Otis CN; Hornick JL; Park PJ; Kim TM; Quade BJ; Morton CC
    Mod Pathol; 2016 May; 29(5):500-10. PubMed ID: 26892441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
    Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
    Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous leiomyomatosis of the uterus. A report of three cases.
    Andrade LA; Torresan RZ; Sales JF; Vicentini R; De Souza GA
    Pathol Oncol Res; 1998; 4(1):44-7. PubMed ID: 9555121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive pelvic recurrence of uterine leiomyomatosis with intracaval-intracardiac extension: video case report and literature review.
    Castagneto Gissey L; Mariano G; Musleh L; Lepiane P; Colasanti M; Meniconi RL; Ranocchi F; Musumeci F; Antonini M; Ettorre GM
    BMC Surg; 2017 Nov; 17(1):118. PubMed ID: 29187188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological Properties of Intravenous Leiomyomatosis: Involvement of Mesenchymal Tumor Stem-Like Cells.
    Tamura S; Hayashi T; Tokunaga H; Yaegashi N; Abiko K; Konishi I
    Curr Issues Mol Biol; 2021 Sep; 43(2):1188-1202. PubMed ID: 34563053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravenous leiomyomatosis of the uterus].
    Banaczek Z; Woźniak M; Grzeszczyk J
    Ginekol Pol; 2003 Feb; 74(2):159-61. PubMed ID: 12715427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).
    Chan E; Rabban JT; Mak J; Zaloudek C; Garg K
    Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.